Back to search

Article

Therapy-Induced Clonal Selection as a Driver of Response to JAK Inhibitors in Myelofibrosis

2026-06-23

Abstract excerpt

Myelofibrosis (MF) originates from the stepwise acquisition of somatic mutations in Hematopoietic Stem and Progenitor Cells (HSPCs). Alongside driver events triggering JAK-STAT pathway hyperactivation, several additional mutations, usually affecting the epigenetic machinery, contribute defining therapeutic response. Specifically, JAK-inhibition (JAKi) relieves MF symptoms but rarely eradicates the neoplastic clon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
690f8406-5a14-5e1a-9ed4-10e3829c1048
DOI
10.64898/2026.06.20.733514
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapy-Induced Clonal Selection as a Driver of Response to JAK Inhibitors in MyelofibrosisDOI 10.64898/2026.06.20.733514
Select a neighboring publication to make it the new centre.